Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LPAR5 | Q9H1C0 | 3/20 | 0.54 |
| ▸ | PGK1 | P00558 | 1/20 | 0.45 |
| ▸ | PGK2 | P07205 | 1/20 | 0.45 |
| ▸ | LPAR1 | Q92633 | 6/20 | 0.42 |
| ▸ | LPAR4 | Q99677 | 2/20 | 0.42 |
| ▸ | LPAR2 | Q9HBW0 | 2/20 | 0.42 |
| ▸ | LPAR3 | Q9UBY5 | 2/20 | 0.42 |
| ▸ | ENPP2 | Q13822 | 2/20 | 0.42 |
| ▸ | LPAR6 | P43657 | 1/20 | 0.42 |
| ▸ | PGD | P52209 | 3/20 | 0.42 |
| ▸ | MPI | P34949 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | USP2 | O75604 | 1/20 | 0.37 |
| ▸ | CES2 | O00748 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3950043 | 0.91 | LPAR5 (0.61) | LPAR5PGK1PGK2LPAR1LPAR4 | |
| SCHEMBL14278848 | 0.91 | PGK1 (0.52) | LPAR5PGK1PGK2LPAR1LPAR4 | |
| SCHEMBL7340 | 0.91 | PGK1 (0.52) | LPAR5PGK1PGK2LPAR1LPAR4 | |
| SCHEMBL14278847 | 0.91 | PGK1 (0.52) | LPAR5PGK1PGK2LPAR1LPAR4 | |
| SCHEMBL6655023 | 0.91 | PGK1 (0.52) | LPAR5PGK1PGK2LPAR1LPAR4 | |
| SCHEMBL7341 | 0.91 | PGK1 (0.52) | LPAR5PGK1PGK2LPAR1LPAR4 | |
| SCHEMBL213379 | 0.91 | PGK1 (0.52) | LPAR5PGK1PGK2LPAR1LPAR4 | |
| SCHEMBL468639 | 0.89 | PGK1 (0.50) | LPAR5PGK1PGK2LPAR1LPAR4 | |
| Iodide SCHEMBL7627762 | 0.89 | PGK1 (0.50) | LPAR5PGK1PGK2LPAR1LPAR4 | |
| SCHEMBL1134754 | 0.89 | PGK1 (0.50) | LPAR5PGK1PGK2LPAR1LPAR4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1641930-A4 | NUCLEIC ACID SEQUENCES ENCODING PROTEINS ASSOCIATED WITH ABIOTIC STRESS RESPONSE AND PLANT CELLS AND PLANTS WITH INCREASED TOLERANCE TO ENVIRONMENTAL STRESS | BASF PLANT SCIENCE GMBH (DE) | 2008-06-11 | — | — | EP | claimed |
| EP-1641930-A2 | NUCLEIC ACID SEQUENCES ENCODING PROTEINS ASSOCIATED WITH ABIOTIC STRESS RESPONSE AND PLANT CELLS AND PLANTS WITH INCREASED TOLERANCE TO ENVIRONMENTAL STRESS | BASF Plant Science GmbH (DE) | 2006-04-05 | — | — | EP | claimed |
| WO-2004092398-A2 | NUCLEIC ACID SEQUENCES ENCODING PROTEINS ASSOCIATED WITH ABIOTIC STRESS RESPONSE AND PLANT CELLS AND PLANTS WITH INCREASED TOLERANCE TO ENVIRONMENTAL STRESS | BASF PLANT SCIENCE GMBH (DE) | 2004-10-28 | — | — | WO | claimed |
| US-11168340-B2 | Compositions and methods for producing lipids and other biomaterials from grain ethanol stillage and stillage derivatives | XYLOME CORPORATION (US) | 2021-11-09 | — | — | US | disclosed |
| US-20200270651-A1 | COMPOSITIONS AND METHODS FOR PRODUCING LIPIDS AND OTHER BIOMATERIALS FROM GRAIN ETHANOL STILLAGE AND STILLAGE DERIVATIVES | XYLOME CORPORATION (US) | 2020-08-27 | — | — | US | disclosed |
| US-10662448-B2 | Compositions and methods for producing lipids and other biomaterials from grain ethanol stillage and stillage derivatives | XYLOME CORPORATION (US) | 2020-05-26 | — | — | US | disclosed |
| CN-110251463-A | Lotion containing hormone | 贝朗医疗有限公司 | 2019-09-20 | — | — | CN | disclosed |
| US-20180245109-A1 | COMPOSITIONS AND METHODS FOR PRODUCING LIPIDS AND OTHER BIOMATERIALS FROM GRAIN ETHANOL STILLAGE AND STILLAGE DERIVATIVES | XYLOME CORPORATION (US) | 2018-08-30 | — | — | US | disclosed |
| CN-108348468-A | PEGylated Lipid Nanoparticles with Bioactive Lipophilic Compounds | EYESIU医疗股份有限公司 | 2018-07-31 | — | — | CN | disclosed |
| CN-107889458-A | For administration cavitation seed and utilize its medication | 太平洋系统有限公司 | 2018-04-06 | — | — | CN | disclosed |
| EP-3151665-A1 | METHODS AND SYSTEMS FOR DETERMINING AUTISM SPECTRUM DISORDER RISK | Laboratory Corporation of America Holdings (US) | 2017-04-12 | — | — | EP | disclosed |
| WO-2015157601-A1 | METHODS AND SYSTEMS FOR DETERMINING AUTISM SPECTRUM DISORDER RISK | SYNAPDX CORPORATION (US) | 2015-10-15 | — | — | WO | disclosed |
| US-7691603-B2 | Intracellular formation of peptide conjugates | NOVO NORDISK A/S (DK) | 2010-04-06 | — | — | US | disclosed |
| US-20060177892-A1 | Intracellular formation of peptide conjugates | NOVO NORDISK A/S (DK) | 2006-08-10 | — | — | US | disclosed |
| EP-1097216-B1 | METABOLICALLY ENGINEERED MICROBIAL CELL WITH AN ALTERED METABOLITE PRODUCTION | FLUXOME SCIENCES AS (DK) | 2006-05-03 | — | — | EP | disclosed |
| EP-1097217-A2 | METABOLICALLY ENGINEERED MICROBIAL CELL COMPRISING A MODIFIED REDOX ACTIVITY | Nielsen, Jens (DK) | 2001-05-09 | — | — | EP | disclosed |
| WO-2000003021-A2 | METABOLICALLY ENGINEERED MICROBIAL CELL COMPRISING A MODIFIED REDOX ACTIVITY | NIELSEN JENS (DK) | 2000-01-20 | — | — | WO | disclosed |